TY - JOUR
T1 - Incidence of clinical fractures: A 7-year follow-up study in institutionalized adults with epilepsy and intellectual disability
AU - Berkvens, J.J.L.
AU - Wyers, C.E.
AU - Mergler, S.
AU - Beerhorst, K.
AU - Verschuure, P.
AU - Tan, I.Y.
AU - Majoie, H.J.M.
AU - van den Bergh, J.P.W.
PY - 2021/11/1
Y1 - 2021/11/1
N2 - Purpose: To determine the incidence of clinical fractures over seven years of follow-up, in adults with epilepsy and intellectual disability, residing in a long-stay care facility. Methods: In 2009, all institutionalized adult patients (n = 261) were invited to undergo a Dual-energy X-ray Absorptiometry (DXA) measurement and a Vertebral Fracture Assessment (VFA). Participants were followed over seven years or until date of discharge (in case of moving from the care facility) or date of death. The patients' medical files were screened for radiology reports and staff notes, to identify clinical fractures. Fracture incidence rates (IR) were determined and compared for subgroups, by calculating incidence rate ratios. Hazard ratios were calculated to identify factors associated with fracture risk, using Cox Proportional Hazards analyses. Results: A total of 205 patients (124 male, 60.5%) aged between 18 and 88 years (median 48, IQR 34-60) were enrolled. At baseline, 92 patients (44.9%) were diagnosed with osteopenia and 65 (31.7%) with osteoporosis. Between 2009 and 2016, 30 patients (14.6%) deceased and 3 patients (1.5%) left the care facility. During followup, 156 clinical fractures were reported in 82 patients (40.0%). Thirty-eight patients (18.5%) had at least one major osteoporotic fracture. Overall, the IR was 11.6 fractures per 100 person-years. Fracture risk was significantly lower in patients who were wheelchair dependent than in patients who were able to walk (p<.001). Conclusion: This study demonstrated that 40% of institutionalized adults with epilepsy and intellectual disability had at least one clinical fracture during seven years of follow-up, despite adequate anti-osteoporosis treatment.
AB - Purpose: To determine the incidence of clinical fractures over seven years of follow-up, in adults with epilepsy and intellectual disability, residing in a long-stay care facility. Methods: In 2009, all institutionalized adult patients (n = 261) were invited to undergo a Dual-energy X-ray Absorptiometry (DXA) measurement and a Vertebral Fracture Assessment (VFA). Participants were followed over seven years or until date of discharge (in case of moving from the care facility) or date of death. The patients' medical files were screened for radiology reports and staff notes, to identify clinical fractures. Fracture incidence rates (IR) were determined and compared for subgroups, by calculating incidence rate ratios. Hazard ratios were calculated to identify factors associated with fracture risk, using Cox Proportional Hazards analyses. Results: A total of 205 patients (124 male, 60.5%) aged between 18 and 88 years (median 48, IQR 34-60) were enrolled. At baseline, 92 patients (44.9%) were diagnosed with osteopenia and 65 (31.7%) with osteoporosis. Between 2009 and 2016, 30 patients (14.6%) deceased and 3 patients (1.5%) left the care facility. During followup, 156 clinical fractures were reported in 82 patients (40.0%). Thirty-eight patients (18.5%) had at least one major osteoporotic fracture. Overall, the IR was 11.6 fractures per 100 person-years. Fracture risk was significantly lower in patients who were wheelchair dependent than in patients who were able to walk (p<.001). Conclusion: This study demonstrated that 40% of institutionalized adults with epilepsy and intellectual disability had at least one clinical fracture during seven years of follow-up, despite adequate anti-osteoporosis treatment.
KW - Epilepsy
KW - Intellectual disability
KW - Antiseizure drugs (ASD)
KW - Bone mineral density (BMD)
KW - Fractures
KW - BONE-MINERAL DENSITY
KW - ANTIEPILEPTIC DRUG
KW - OSTEOPOROSIS
KW - RISK
KW - CHILDREN
KW - THERAPY
KW - PEOPLE
U2 - 10.1016/j.seizure.2021.08.009
DO - 10.1016/j.seizure.2021.08.009
M3 - Article
C2 - 34438165
SN - 1059-1311
VL - 92
SP - 56
EP - 61
JO - SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
JF - SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
ER -